Recursion Pharmaceuticals, Inc. (BMV:RXRX)
Mexico
· Delayed Price · Currency is MXN 105.75
+6.75 (6.82%)
At close: Aug 14, 2025
Recursion Pharmaceuticals Revenue
Recursion Pharmaceuticals had revenue of $19.22M USD in the quarter ending June 30, 2025, with 33.34% growth. This brings the company's revenue in the last twelve months to $64.60M, up 30.14% year-over-year. In the year 2024, Recursion Pharmaceuticals had annual revenue of $58.84M with 32.00% growth.
Revenue (ttm)
$64.60M
Revenue Growth
+30.14%
P/S Ratio
38.49
Revenue / Employee
$80.75K
Employees
800
Market Cap
46.89B MXN
Revenue Chart
* This company reports financials in USD.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Wal-Mart de México | 991.14B |
| Grupo Financiero Banorte | 134.12B |
| Arca Continental | 250.59B |
| Industrias Peñoles | 141.36B |
| GMéxico Transportes | 62.95B |
| FIBRA Prologis | 13.44B |
| Promotora y Operadora de Infraestructura, S. A. B. de C. V. | 18.98B |
| Fibra UNO | 30.16B |